Related Experiment Video
Updated: Jun 16, 2026
08:12
Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
Maternal HIV seroconversion at delivery without transmission
Paul N Goldwater1, Vineesh Bhatia, Celia Cooper
1SA Pathology at the Women's Children's Hospital, University of Adelaide School of Paediatrics and Reproductive Health, 72 King William Road, North Adelaide, South Australia 5006, Australia. paul.goldwater@health.sa.gov.au
Journal of Paediatrics and Child Health
|February 19, 2010
Summary
This case study highlights HIV seroconversion near delivery with high viral load. It details management strategies for preventing mother-to-child HIV transmission and outlines a care plan for delivery and newborns.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Pediatrics
Background:
- Human Immunodeficiency Virus (HIV) infection poses risks during pregnancy.
- High viral load near delivery increases the likelihood of mother-to-child transmission (MTCT).
- Effective management is crucial for preventing vertical HIV transmission.
Observation:
- A case of HIV seroconversion was identified in a mother at or near the time of delivery.
- The patient presented with a high viral load.
- This scenario presents a critical window for potential HIV transmission to the infant.
Findings:
- The case underscores the importance of timely HIV diagnosis and intervention.
- Management focused on preventing MTCT, guided by current literature and clinical guidelines.
- Specific interventions were implemented during delivery and immediate postnatal care.
Implications:
- The case provides a basis for developing a robust strategy for delivery management in high-risk scenarios.
- Immediate postnatal care protocols can be refined to mitigate MTCT risks.
- This instructive case contributes to best practices in obstetric HIV management and infant protection.
Related Concept Videos
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:24Transmission of Pathogens
Pathogens spread from their reservoirs to susceptible hosts through three main routes: contact transmission, vehicle transmission, and vector transmission. Each route involves distinct mechanisms of transfer.Contact TransmissionThis category includes direct contact, indirect contact, and droplet transmission:Direct contact involves immediate physical interaction between individuals—such as a handshake—which can spread pathogens like Streptococcus pyogenes, the bacterium responsible for...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...